4.7 Article

Unexpected role of the phosphate carrier in mitochondrial fragmentation

期刊

CELL DEATH AND DIFFERENTIATION
卷 15, 期 3, 页码 616-618

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/sj.cdd.4402295

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

Identification of HPCAL1 as a specific autophagy receptor involved in ferroptosis

Xin Chen, Xinxin Song, Jingbo Li, Ruoxi Zhang, Chunhua Yu, Zhuan Zhou, Jiao Liu, Siyan Liao, Daniel J. Klionsky, Guido Kroemer, Jinbao Liu, Daolin Tang, Rui Kang

Summary: This study identifies HPCAL1 as a novel autophagy receptor for the selective degradation of CDH2 during ferroptosis. Depletion of CDH2 increases susceptibility to ferroptotic death. The phosphorylation of HPCAL1 and the non-classical LC3-interacting region motif play key roles in the autophagic degradation of CDH2. A ferroptosis inhibitor is found to suppress HPCAL1 expression. Inhibition of HPCAL1 prevents ferroptosis-induced tumor suppression and pancreatitis in mouse models.

AUTOPHAGY (2023)

Review Gastroenterology & Hepatology

Endoplasmic reticulum stress in liver diseases

Amir Ajoolabady, Neil Kaplowitz, Cynthia Lebeaupin, Guido Kroemer, Randal J. Kaufman, Harmeet Malhi, Jun Ren

Summary: The endoplasmic reticulum stress and unfolded protein response play important roles in the pathophysiology of liver diseases. Understanding this process is crucial for developing interventions for the treatment of nonmalignant liver diseases.

HEPATOLOGY (2023)

Editorial Material Cell Biology

Cardio-, hepato- and pneumoprotective effects of autophagy checkpoint inhibition by targeting DBI/ACBP

Omar Motino, Flavia Lambertucci, Gerasimos Anagnostopoulos, Sijing Li, Isabelle Martins, Guido Kroemer

Summary: DBI/ACBP acts as a paracrine inhibitor of autophagy and its neutralization by a monoclonal antibody has cytoprotective effects on various organs. This study reveals a potentially useful strategy for enhancing autophagy by targeting DBI/ACBP, and provides new insights into the protective mechanisms of autophagy in organ damage.

AUTOPHAGY (2023)

Article Cell Biology

High plasma concentrations of acyl-coenzyme A binding protein (ACBP) predispose to cardiovascular disease: Evidence for a phylogenetically conserved proaging function of ACBP

Lea Montegut, Adrien Joseph, Hui Chen, Mahmoud Abdellatif, Christoph Ruckenstuhl, Omar Motino, Flavia Lambertucci, Gerasimos Anagnostopoulos, Sylvie Lachkar, Silvia Dichtinger, Maria Chiara Maiuri, Francois Goldwasser, Benoit Blanchet, Frederic Fumeron, Isabelle Martins, Frank Madeo, Guido Kroemer

Summary: Autophagy defects accelerate aging, while activation of autophagy slows down aging. Acyl-coenzyme A binding protein (ACBP), encoded by diazepam-binding inhibitor (DBI), acts as an extracellular regulator of autophagy. Knockout of ACBP gene in yeast improves chronological aging, and this effect is reversed by knockout of autophagy genes but less so by knockout of mitophagy gene. In humans, ACBP levels correlate with body mass index (BMI) and age, with high ACBP levels predicting future cardiovascular events independently of BMI and age. ACBP plasma concentrations in mice are associated with cardiovascular risk factors and can be attenuated by a monoclonal antibody, suggesting its prognostic value in cardiovascular disease.

AGING CELL (2023)

Editorial Material Cell Biology

DBI/ACBP is a targetable autophagy checkpoint involved in aging and cardiovascular disease

Lea Montegut, Adrien Joseph, Hui Chena, Mahmoud Abdellatif, Christoph Ruckenstuhlg, Isabelle Martins, Frank Madeo, Guido Kroemer

Summary: DBI/ACBP is a conserved paracrine inhibitor that regulates autophagy and lifespan. Its increased levels in humans are associated with biological age and cardiovascular disease risk factors. Studies have shown that neutralizing DBI/ACBP can alleviate cardiac aging. Therefore, it may serve as a potential target for treating age-associated cardiovascular diseases.

AUTOPHAGY (2023)

Article Cell Biology

Copper-dependent autophagic degradation of GPX4 drives ferroptosis

Qian Xue, Ding Yan, Xi Chen, Xiaofen Li, Rui Kang, Daniel J. J. Klionsky, Guido Kroemer, Xin Chen, Daolin Tang, Jinbao Liu

Summary: Ferroptosis is an iron-dependent regulated cell death characterized by lipid peroxidation and membrane damage. Copper promotes ferroptotic cell death by inducing autophagic degradation of GPX4. These findings provide new insights into the connection between metal stress and autophagy-dependent cell death.

AUTOPHAGY (2023)

Review Medicine, Research & Experimental

Immunogenic cell death in cancer: concept and therapeutic implications

Lorenzo Galluzzi, Oliver Kepp, Erik Hett, Guido Kroemer, Francesco M. Marincola

Summary: Mammalian cells can undergo regulated cell death in response to specific disruptions of homeostasis, leading to adaptive immune responses. This immunogenic cell death (ICD) is distinct from immunostimulation or inflammatory responses that do not depend on cellular demise. In this article, we critically discuss the key concepts and mechanisms of ICD and its implications for cancer immunotherapy.

JOURNAL OF TRANSLATIONAL MEDICINE (2023)

Editorial Material Oncology

Tumor-infiltrating lymphocytes for melanoma immunotherapy

Oliver Kepp, Peng Liu, Laurence Zitvogel, Guido Kroemer

ONCOIMMUNOLOGY (2023)

Editorial Material Oncology

Arsenic trioxide as an inducer of immunogenic cell death

Oliver Kepp, Hui Pan, Peng Liu, Guido Kroemer

ONCOIMMUNOLOGY (2023)

Editorial Material Oncology

Prevention and treatment of cancers by tumor antigen-expressing Staphylococcus epidermidis

Oliver Kepp, Laurence Zitvogel, Guido Kroemer

Summary: In a recent paper in Science, Chen et al. conducted genetic engineering to produce S. epidermidis strains that express tumor cross-reactive antigens. Topical administration of these strains triggered T cell responses and exhibited anticancer effects. Here, the authors discussed both the direct local effects and indirect systemic effects of exposure to engineered S. epidermidis strains.

ONCOIMMUNOLOGY (2023)

Review Oncology

Trial watch: chemotherapy-induced immunogenic cell death in oncology

Jenny Sprooten, Raquel S. Laureano, Isaure Vanmeerbeek, Jannes Govaerts, Stefan Naulaerts, Daniel M. Borras, Lisa Kinget, Jitka Fucikova, Radek Spisek, Lenka Palova Jelinkova, Oliver Kepp, Guido Kroemer, Dmitri V. Krysko, An Coosemans, Rianne D. W. Vaes, Dirk De Ruysscher, Steven De Vleeschouwer, Els Wauters, Evelien Smits, Sabine Tejpar, Benoit Beuselinck, Sigrid Hatse, Hans Wildiers, Paul M. Clement, Peter Vandenabeele, Laurence Zitvogel, Abhishek D. Garg

Summary: Immunogenic cell death (ICD) is a unique process of regulated cell death that activates the immune system. The effectiveness of ICD relies on the antigenicity of dying cells and their ability to expose immunostimulatory molecules. Certain chemotherapies, such as anthracyclines, paclitaxels, and oxaliplatin, have been validated as potent ICD inducers and can be used in combination with immunotherapies against resistant tumors. This article discusses the integration of ICD-inducing chemotherapy in immuno-oncological paradigms.

ONCOIMMUNOLOGY (2023)

Article Cell Biology

Identification of Small Molecules Affecting the Secretion of Therapeutic Antibodies with the Retention Using Selective Hook (RUSH) System

Mathilde Coulet, Sylvie Lachkar, Marion Leduc, Marc Trombe, Zelia Gouveia, Franck Perez, Oliver Kepp, Guido Kroemer, Stephane Basmaciogullari

Summary: In this study, a selective hook system called RUSH was used to identify cell secretion modulators in U2OS cells. They created a U2OS cell line that expressed a modified antibody bait and a streptavidin hook, which allowed the antibody to be retained in the endoplasmic reticulum (ER). Biotin was used to trigger the release of the antibody from the ER, resulting in its secretion.
Article Cell Biology

Impact of microbiota on breast cancer hormone therapy

Safae Terrisse, Laurence Zitvogel, Guido Kroemer

Summary: Recent observations show that hormone-receptor breast cancer is influenced by immune and microbial factors. The immune system retards the development of hormone-positive breast cancer and affects the efficacy of hormone therapy. The gut microbiota modulates the anticancer immune response, tumor microenvironment, and estrogen metabolism. Understanding these mechanisms is still in its early stages and requires further analysis.

CELL STRESS (2023)

Editorial Material Oncology

A mitochondrial checkpoint to adaptive anticancer immunity

Oliver Kepp, Peng Liu, Guido Kroemer, Lorenzo Galluzzi

Summary: BCL2 robustly maintains mitochondrial integrity, inhibits immune signaling and cell death, and limits the ability of dendritic cells to initiate adaptive immune responses, suggesting a universal immunosuppressive function for the mitochondrial immune checkpoint.

ONCOIMMUNOLOGY (2023)

暂无数据